P

Inventor

ELIOTT DEAN

US9 patents
⚠️ This page may combine multiple inventors who share the name “ELIOTT DEAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MASSACHUSETTS EYE & EAR INFIRMARY

5 patents
US10881548B2Jan 5, 2021

Methods of delivering an agent to the eye

MASSACHUSETTS EYE & EAR INFIRMARY8 citations80
US10828306B2Nov 10, 2020

Methotrexate for proliferative vitreoretinopathy

MASSACHUSETTS EYE & EAR INFIRMARY1 citations67
US10098884B2Oct 16, 2018

Methotrexate for proliferative vitreoretinopathy

MASSACHUSETTS EYE & EAR INFIRMARY3 citations67
US11963905B2Apr 23, 2024

Methods of delivering an agent to the eye

MASSACHUSETTS EYE & EAR INFIRMARY0 citations59
US10272089B2Apr 30, 2019

Methotrexate for proliferative vitreoretinopathy

MASSACHUSETTS EYE & EAR INFIRMARY0 citations46

ALDEYRA THERAPEUTICS INC

3 patents
US12005061B2Jun 11, 2024

Ophthalmic formulations of methotrexate

ALDEYRA THERAPEUTICS INC0 citations58
US12005060B2Jun 11, 2024

Ophthalmic formulations of methotrexate

ALDEYRA THERAPEUTICS INC0 citations58
US11911385B1Feb 27, 2024

Methotrexate treatment methods

ALDEYRA THERAPEUTICS INC1 citations57

SCHEPENS EYE RES INST

1 patent
US11739326B2Aug 29, 2023

RUNX1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition

SCHEPENS EYE RES INST1 citations54